Charite N. Ricker, MS, CGC

Assistant Professor Of Clinical Medicine

Image of Charite N. Ricker, MS, CGC
Is this your profile? Click to edit

Overview

Charité Ricker, MS is a genetic counselor with the USC Norris Comprehensive Cancer Center and Clinical Instructor of Medicine in the USC Keck School of Medicine. She leads the genetic counseling team at Los Angeles General Medical Center for individuals and family at risk of having inherited cancer syndromes.

Ms. Ricker has extensive experience as a cancer genetic counselor and the majority of her clinical work has been in the underserved patient setting. Her particular research interest is focused on the provision of genetic services to ethnically diverse patient populations and its impact and the outcomes.

Research Funding

  • Increasing Access to Genetic Testing in Underserved Patients Using a Multilingual Conversational Agent
    NIH · R01CA263532 · Jun 1, 2022 – May 31, 2026 · Role: Principal Investigator

Publications

  • Socioeconomic and Clinical Determinants Driving Access to BRCA Genetic Testing in Cancer : A Case-Control Study Using Observational Electronic Health Records Across Multiple Sites. medRxiv. 2026 May 21.. View in PubMed
  • Provider perceptions and insights on polygenic risk scores for colorectal cancer: A qualitative study. J Genet Couns. 2025 12; 34(6):e70135.. View in PubMed
  • Patient-centered integration of tumor and germline genetic results can improve cancer care. Nat Med. 2025 Oct; 31(10):3248-3251.. View in PubMed
  • Optimizing participant and community engagement in cancer genomic sequencing research. Genet Med. 2025 Sep; 27(9):101483.. View in PubMed
  • The impact of language discordance on genetic counselors’ ability to establish a working alliance with patients. J Genet Couns. 2025 06; 34(3):e70019.. View in PubMed
  • Interpreter use in telehealth genetic counseling sessions. J Genet Couns. 2025 04; 34(2):e2026.. View in PubMed
  • Assessment of MYC Gene and WNT Pathway Alterations in Early-Onset Colorectal Cancer Among Hispanic/Latino Patients Using Integrated Multi-Omics Approaches. medRxiv. 2025 Feb 22.. View in PubMed
  • Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer. Eur J Hum Genet. 2025 03; 33(3):297-303.. View in PubMed
  • Breast Cancer MRI Screening of Patients After Multiplex Gene Panel Testing. JAMA Netw Open. 2025 01 02; 8(1):e2454447.. View in PubMed
  • Integrative multi-omics profiling of colorectal cancer from a Hispanic/Latino cohort of patients. medRxiv. 2024 Nov 15.. View in PubMed